Human leucocyte antigen determinants of susceptibility to Barrett's oesophagus in Asians - A preliminary study

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 11, 2005, Pages 1377-1383

  Rajendra, S ^a   Ackroyd, R ^b   Murad, S ^c   Mohan, C ^d   Ho, J J ^a   Goh, K L ^e   Azrena, A ^c   Too, C L ^c  

^a UNIVERSITI KUALA LUMPUR   (Malaysia)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B7 ANTIGEN;

ADULT; ARTICLE; ASIAN; BARRETT ESOPHAGUS; CHINESE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENDOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; GENE LOCUS; GENOTYPE; HAPLOTYPE; HISTOPATHOLOGY; HLA TYPING; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; BARRETT ESOPHAGUS; COHORT STUDIES; FEMALE; GASTROESOPHAGEAL REFLUX; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HUMANS; MALAYSIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 20444447419     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02496.x     Document Type: Article

References (39)

1. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205-8.
2. Ruth M, Manson I, Sandberg N. The prevalence of symptoms suggestive of esophageal disorders. Scand J Gastroenterol 1991; 26: 73-81.
3. Johnsson F, Joelsson B, Gudmundsson K. et al. Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol 1987; 22: 714-8.
4. Vitale GC, Cheadle WG, Sadek S, et al. Computerised 24-hour ambulatory esophageal pH monitoring and esophago-gastroduodenoscopy in the reflux patient. A comparative study. Ann Surg 1984; 20: 724-8.
5. Howard PJ, Pryde A, Heading RC. Acid exposure times do not identify patients with symptomatic gastroesophageal reflux. Clin Sci 1989: 76 (Suppl. 20): 724-8.
6. Mattioli S, Pilotti V, Spangaro M, et al. Reliability of 24-hour home esophageal monitoring in diagnosis of gastroesophageal reflux disease. Dig Dis Sci 1989; 34: 71-8.
7. Avidan B, Sonnenberg A, Schnell TG, et al. There are no reliable symptoms for erosive oesophagitis and Barrett's oesophagus: endoscopic diagnosis is still essential. Aliment Pharmacol Ther 2002; 16: 735-42.
8. Heading R. Epidemiology of oesophageal reflux disease. Scand J Gastroenterol 1989; 24: 25-36.
9. Winters C, Spurling T, Chobanian S. et al. Barrett's esophagus: a prevalent occult complication of gastro-oesophageal reflux disease. Gastroenterology 1987; 92: 118-24.
10. Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastro-esophageal junction. Lancet 1994; 344: 1533-6.
11. Cameron A, Kamath P, Carpenter H. Prevalence of Barrett's esophagus and intestinal metaplasia at the esophagogastric junction. Gastroenterology 1997; 112: A82.
12. Trudgill NJ, Kapur KC, Riley SA. Familial clustering of reflux symptoms. Am J Gastroenterol 1999; 94: 1172-8.
13. Romero Y, Cameron AJ, Locke GR, et al. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 1997; 113: 1449-56.
14. Jochem VJ, Fuerst PA, Fromkes JJ. Familial Barrett's esophagus associated with adenocarcinoma. Gastroenterology 1992; 102: 1400-2.
15. Eng C, Spechler SJ, Ruben R, et al. Familial Barrett's esophagus and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol Biomarkers Prev 1993; 2: 397-9.
16. Cameron AJ, Lagergren J, Henriksson C, et al. Gastro-esophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology 2001; 122: 55-9.
17. Mohammed I, Cherkas LF, Riley SA, et al. Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut 2003; 52: 1085-9.
18. Neumann CS, Cooper BT. Ethnic differences in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 1999; 11: 735-9.
19. Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol 1998; 93: 1816-22.
20. Rajendra S, Alahuddin S. Racial differences in the prevalence of heartburn. Aliment Pharmacol Ther 2004; 19: 375-6.
21. Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic oesophagitis and Barrett's oesophagus: the long and short of it all. Dig Dis Sci 2004; 49: 237-42.
22. Rosaida MS, Goh KL. Gastroesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study. Eur J Gastroenterol Hepatol 2004; 16: 495-501.
23. Romero Y, Locke GR III. Is there a GERD gene? Am J Gastroenterol 1999; 94: 1127-9.
24. Fitzgerald RC, Onwuegbusi BA, Bajaj-Elliott M, et al. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut 2002; 50: 451-9.
25. Little AM, Stern PL. Does HLA type predispose some individuals to cancer? Mol Med Today 1999; 5: 337-42.
26. Department of Statistics. Population Distribution and Basic Demographic Characteristics. The 2000 Population, Housing Census of Malaysia. Putrajaya, Malaysia: Department of Statistics, 2000.
27. Ismail-Beigi F, Horton P, Pope C. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970; 58: 163-74.
28. Woolf B. On estimating the relationship between blood groups and disease. Ann Hum Genet 1955; 19: 251-3.
29. Cameron AJ, Lomboy CT. Barrett's oesophagus: age, prevalence and extent of columnar epithelium. Gastroenterology 1992; 103: 1241-5.
30. Hu FZ, Preston RA, Post JC, et al. Mapping of a gene for severe pediatric gastroesophageal reflux to chromosome 13q14. JAMA 2000; 284: 325-34.
31. Orenstein SR, Shalaby TM, Pfuetzer RH, et al. Autosomal dominant infant GERD: exclusion of a 13q14 locus in 6 well-characterized families suggests genetic heterogeneity. Gastroenterology 2001; 120: A211.
32. Nordborg M, Tavare S. Linkage disequilibrium: what history has to tell us. Trends Genet 2002; 18: 83-90.
33. Hicklin DJ, Marincola FM, Ferrone S. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Mol Med Today 1999; 5: 178-86.
34. Garrido F, Algarra I. MHC antigens and tumor escape from immune surveillance. Adv Cancer Res 2001; 83: 117-58.
35. Douby DP. Quantitative aspects of HLA. In: Rose, NR, Conway de Macario, E, Fahey, JL, Friedaman, H, Penn, GM, eds. Manual of Clinical Laborartory Immunology, 4th edn. Washington, DC, USA: American Society for Microbiology, 1992.
36. Svejgaard A. HLA and disease. In: Rose, NR, Friedman, H, Fahey, JL, eds. Manual of Clinical Laboratory Immunology, 3rd edn. Washington, DC, USA: American Society for Microbiology, 1986.
37. Rothman KJ, No adjustments are needed for multiple comparisons. Epidemiology 1990; 1; 43-6.
38. Nakajima A, Matsuhashi N, Kodama T, et al. HLA linked susceptibility and resistance genes in Crohn's disease. Gastroenterology 1995; 109: 1462-7.
39. Cariappa A, Sands B, Forcione D, et al. Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease. Gut 1998; 43: 210-5.